company background image
BIOC

GlaxoSmithKlineE CASE:BIOC Stock Report

Last Price

ج.م38.44

Market Cap

ج.م3.2b

7D

30.8%

1Y

52.6%

Updated

04 Dec, 2022

Data

Company Financials
BIOC fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends2/6

BIOC Stock Overview

GlaxoSmithKline S.A.E. operates as a research-based pharmaceutical and healthcare company.

GlaxoSmithKline S.A.E Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GlaxoSmithKlineE
Historical stock prices
Current Share Priceج.م38.44
52 Week Highج.م38.44
52 Week Lowج.م18.70
Beta1.13
1 Month Change71.38%
3 Month Change60.17%
1 Year Change52.60%
3 Year Change94.53%
5 Year Changen/a
Change since IPO312.45%

Recent News & Updates

Recent updates

Shareholder Returns

BIOCEG PharmaceuticalsEG Market
7D30.8%11.5%5.7%
1Y52.6%13.6%15.2%

Return vs Industry: BIOC exceeded the EG Pharmaceuticals industry which returned 13.6% over the past year.

Return vs Market: BIOC exceeded the EG Market which returned 15.2% over the past year.

Price Volatility

Is BIOC's price volatile compared to industry and market?
BIOC volatility
BIOC Average Weekly Movement9.7%
Pharmaceuticals Industry Average Movement4.7%
Market Average Movement5.6%
10% most volatile stocks in EG Market9.1%
10% least volatile stocks in EG Market3.4%

Stable Share Price: BIOC is more volatile than 90% of EG stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: BIOC's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of EG stocks.

About the Company

FoundedEmployeesCEOWebsite
1981n/aAmr Mamdouh Majidhttps://www.gsk.com/en-gb/contact-us/worldwide/egypt

GlaxoSmithKline S.A.E. operates as a research-based pharmaceutical and healthcare company. The company was founded in 1981 and is based in Cairo, Egypt. GlaxoSmithKline S.A.E. is a subsidiary of Glaxo Group Limited.

GlaxoSmithKline S.A.E Fundamentals Summary

How do GlaxoSmithKlineE's earnings and revenue compare to its market cap?
BIOC fundamental statistics
Market Capج.م3.21b
Earnings (TTM)ج.م208.54m
Revenue (TTM)ج.م2.04b

15.4x

P/E Ratio

1.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BIOC income statement (TTM)
Revenueج.م2.04b
Cost of Revenueج.م1.29b
Gross Profitج.م747.81m
Other Expensesج.م539.26m
Earningsج.م208.54m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)2.50
Gross Margin36.62%
Net Profit Margin10.21%
Debt/Equity Ratio0.05%

How did BIOC perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

30%

Payout Ratio